Clovis Oncology, Inc. Long-Term Debt, Maturity, Year Three
Clovis Oncology, Inc. had Long-Term Debt, Maturity, Year Three of $300.00 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2022-08-08
- 2022-06-30: Long-Term Debt, Maturity, Year Three $300.00M.
- 2022-03-31: Long-Term Debt, Maturity, Year Three $300.00M.
- 2018-12-31: Long-Term Debt, Maturity, Year Three $287.50M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2022-06-30 | $300.00M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $300.00M 10-Q · filed 2022-05-05 |
| 2018-12-31 | $287.50M 10-K · filed 2019-02-28 |